DAPSONE 8.5% / NIACINAMIDE 4%- dapsone 8.5% / niacinamide 4% gel
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

DAPSONE 8.5% / NIACINAMIDE 4%

Directions for use

Sincerus Florida, LLC adverse reactions.

DAPSONE 8.5% / NIACINAMIDE 4%
dapsone 8.5% / niacinamide 4% gel

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
DAPSONE (UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302)	DAPSONE	8.5 g in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4)	NIACINAMIDE	4 g in 100 g

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:72934-1066-2	30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	05/01/2019

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		05/01/2019

Labeler - Sincerus Florida, LLC (080105003)

Name	Address	ID/FEI	Business Operations
Establishment
Sincerus Florida, LLC		080105003	manufacture(72934-1066)